
# Title 15 - Commerce and Foreign Trade
## Subtitle B - Regulations Relating to Commerce and Foreign Trade
### Chapter VII - Bureau of Industry and Security, Department of Commerce
#### Subchapter C - Export Administration Regulations
##### PART 774 - THE COMMERCE CONTROL LIST
###### Supplement No. 1 to Part 774 - The Commerce Control List
####### or

(b) Ricinus communis LectinIV (RCL), also known as ricin E;

(c) Saxitoxin identified by C.A.S. #35523-89-8.

(2) The export of a "medical product" that is an "Investigational New Drug" (IND), as defined in 21 CFR 312.3, is subject to certain U.S. Food and Drug Administration (FDA) requirements that are independent of the export requirements specified in this ECCN or elsewhere in the EAR. These FDA requirements are described in 21 CFR 312.110 and must be satisfied in addition to any requirements specified in the EAR.

(3) Also see 21 CFR 314.410 for FDA requirements concerning exports of new drugs and new drug substances.

a. Vaccines containing, or designed for use against, items controlled by ECCN 1C351, 1C353 or 1C354.

b. Immunotoxins containing toxins controlled by 1C351.d;

c. Medical products that contain any of the following:
